Clinical Trial Update: Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 dose-escalation and dose-expansion study of anti-CD7 allogeneic CAR T-cells (WU-CART-007) in CD7+ hematologic mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Enteropathy-associated T-cell Lymphoma
• Extranodal Nk T-cell Lymphoma
• Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
• Peripheral T-cell Lymphoma
• T-cell Leukemia Lymphoma
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• WU-CART-007

Snippet

Sponsor: Washington University School of Medicine | Conditions: T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING